US Patent 10864194 Methods for treating heterotopic ossification

Patent 10864194 was granted and assigned to Clementia Pharmaceuticals on December, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

‌

Clementia Pharmaceuticals

Current Assignee

‌

Clementia Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

108641940

Date of Patent

December 15, 2020

Patent Application Number

163080120

Date Filed

June 8, 2017

Patent Citations Received

‌

US Patent 12023312 Composition and method for muscle repair and regeneration

‌

US Patent 11622959 Methods for treating heterotopic ossification

‌

US Patent 11433039 Composition and method for muscle repair and regeneration

Patent Primary Examiner

‌

Raymond J. Henley, III

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10864194 Methods for treating heterotopic ossification

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API